PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

Fran Gregory, PharmD, MBA, VP of emerging therapies at Cardinal Health, talks about the importance of market access strategies in the cell and gene therapy space.

People with diseases caused by rare mutations have fewer options and poorer prospects than other patients despite rapid ...

Emma Weston joined the clinical trial after running out of treatment options. For two years, she's been cancer free.

Announcing a new article publication for BIO Integration journal. Bladder cancer (BLCA) is one of the most common malignancies and the second most frequent urogenital tract tumor.

That's the promise behind Minicircle, a gene therapy startup with lofty ambitions. As Founder and CEO Mac Davis put it ...

Dr. Soliman Abdel Kader Fakeeh Hospital Co. (Fakeeh Care) and its subsidiaries signed a strategic memorandum of understanding ...

The influenza virus manipulates the body's gene regulation system to accelerate its own spread, according to researchers at the University of Gothenburg.

Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of ...